Literature DB >> 15533608

Exacerbation of rheumatoid arthritis following Helicobacter pylori eradication: disruption of established oral tolerance against heat shock protein?

Yoshihiro Matsukawa1, Yasukiyo Asai, Noboru Kitamura, Shigemasa Sawada, Hanzo Kurosaka.   

Abstract

A 62-year-old Japanese woman with RA received an eradication therapy against Helicobacter pylori in November 1999. Eight weeks later, successful eradication was confirmed by negative results for rapid urease test, pathologic findings, and a fall in anti-H. pylori IgG antibody titer. During the course, parameters for RA activity were exacerbated: C-reactive protein 1.1-4.2 mg/dL, rheumatoid arthritis precipitation antigen 2560-5120 dils., erythrocyte sedimentation rate 52-123 mm/h, and complements CH50 50 to over 60 U/mL. Lansbury index increased from 70% to 105%. Two more weeks later, the patient noticed right shoulder pain. She also complained of bilateral gonalgia two months later, and physical examination revealed increased fluid in the knee joints. Prednisolone was required to control the disease activity. The results of this case suggested that RA patients might experience a deleterious effect on the disease activity following H. pylori eradication possibly through disruption of the established oral tolerance against stress protein such as mycobacterial heat shock protein 65.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15533608     DOI: 10.1016/j.mehy.2004.06.021

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  6 in total

Review 1.  Role of Helicobacter pylori infection in autoimmune systemic rheumatic diseases.

Authors:  Mislav Radić
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

2.  Higher serum levels of rheumatoid factor and anti-nuclear antibodies in helicobacter pylori-infected peptic ulcer patients.

Authors:  Abdollah Jafarzadeh; Maryam Nemati; Mohammad Taghi Rezayati; Mansooreh Nabizadeh; Medhi Ebrahimi
Journal:  Oman Med J       Date:  2013-07

Review 3.  Helicobacter pylori and autoimmune diseases.

Authors:  S Hasni; A Ippolito; G G Illei
Journal:  Oral Dis       Date:  2011-03-29       Impact factor: 3.511

Review 4.  Clinical proteomics identifies potential biomarkers in Helicobacter pylori for gastrointestinal diseases.

Authors:  Chun-Hao Huang; Shyh-Horng Chiou
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

Review 5.  Helicobacter pylori and autoimmune disease: cause or bystander.

Authors:  Daniel S Smyk; Andreas L Koutsoumpas; Maria G Mytilinaiou; Eirini I Rigopoulou; Lazaros I Sakkas; Dimitrios P Bogdanos
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

Review 6.  Helicobacter pylori-Mediated Protection against Extra-Gastric Immune and Inflammatory Disorders: The Evidence and Controversies.

Authors:  Karen Robinson
Journal:  Diseases       Date:  2015-03-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.